Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of the National Comprehensive Cancer Network : JNCCN|July 15, 2018
Geographic Variation in Postoperative Imaging for Low-Risk Breast CancerBenjamin L Franc, Timothy P Copeland, Robert Thombley, et al.Cancer Imaging : the Official Publication of the International Cancer Imaging Society|June 7, 2022
Does the addition of whole-body MRI to routine imaging influence real-world treatment decisions in metastatic breast cancer?Basrull N Bhaludin, Nina Tunariu, Nishanthi Senthivel, et al.Clinical Lymphoma, Myeloma & Leukemia|September 21, 2023
Outcomes of Patients Treated With RCHOP With a PET-Adapted Approach for Consolidative Radiotherapy: A Retrospective Single-Center Study at the Royal Marsden HospitalSu Li, Bhupinder Sharma, Siraj Yusuf, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 3, 2022
Cost and clinical benefit of imaging surveillance after treatment for breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)Rachel L O'Connell, Bhupinder Sharma, Liza Van Kerckhoven, et al.Frontiers in Medicine|November 18, 2021
Immune Checkpoint Inhibitor and Radiotherapy-Related Pneumonitis: An Informatics Approach to Determine Real-World Incidence, Severity, Management, and Resource ImplicationsSumeet Hindocha, Des Campbell, Merina Ahmed, et al.Radiology. Imaging Cancer|September 24, 2021
Prospective Evaluation of Whole-Body MRI versus FDG PET/CT for Lesion Detection in Participants with MyelomaChristina Messiou, Nuria Porta, Bhupinder Sharma, et al.European Radiology|May 6, 2026
Semantic CT features and differentiation model: new primary lung cancer versus metastasis after previous malignancyHardeep Singh Kalsi, Kristofer Linton-Reid, Changhyun Kim, et al.The Lancet. Haematology|April 29, 2018
CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trialMary Gleeson, Clare Peckitt, Ye Mong To, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 6, 2024
Validated machine learning tools to distinguish immune checkpoint inhibitor, radiotherapy, COVID-19 and other infective pneumonitisSumeet Hindocha, Benjamin Hunter, Kristofer Linton-Reid, et al.Pageof 3